These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26398910)

  • 1. Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study.
    Pelton GH; Soleimani L; Roose SP; Tabert MH; Devanand DP
    Alzheimer Dis Assoc Disord; 2016; 30(1):67-9. PubMed ID: 26398910
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin E and donepezil for the treatment of mild cognitive impairment.
    Marder K
    Curr Neurol Neurosci Rep; 2005 Sep; 5(5):337-8. PubMed ID: 16131415
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.
    Rao NP; Palaniyappan P; Chandur J; Venkatasubramanian G; Gangadhar BN
    J ECT; 2009 Sep; 25(3):216-8. PubMed ID: 19190508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donepezil for cognitive deficits following traumatic brain injury: a case report.
    Bourgeois JA; Bahadur N; Minjares S
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):463-4. PubMed ID: 12426418
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylcholinesterase inhibitor donepezil in the treatment of cognitive deficit in schizophrenia. Subanalysis of the active branch from Czech extended double blind study.
    Pérez M; Tůma I; Pytela O; Kadlecová E; Zemanová M; Lenderová Z
    Eur Psychiatry; 2006 Dec; 21(8):548-50. PubMed ID: 16797936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
    Devanand DP; Lentz C; Chunga RE; Ciarleglio A; Scodes JM; Andrews H; Schofield PW; Stern Y; Huey ED; Bell K; Pelton GH
    J Alzheimers Dis; 2017; 60(4):1525-1531. PubMed ID: 29081417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.
    Pelton GH; Harper OL; Tabert MH; Sackeim HA; Scarmeas N; Roose SP; Devanand DP
    Int J Geriatr Psychiatry; 2008 Jul; 23(7):670-6. PubMed ID: 18088076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognition-enhancing effects of donepezil in traumatic brain injury.
    Khateb A; Ammann J; Annoni JM; Diserens K
    Eur Neurol; 2005; 54(1):39-45. PubMed ID: 16118495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
    Stiles MM; Martin S; Persons RK
    J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
    Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
    J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-week open-label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late-life bipolar disorder.
    Gildengers AG; Butters MA; Chisholm D; Reynolds CF; Mulsant BH
    Int J Geriatr Psychiatry; 2008 Jul; 23(7):693-8. PubMed ID: 18172910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia.
    Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC
    Cogn Neuropsychiatry; 2007 Sep; 12(5):412-21. PubMed ID: 17690999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Donepezil therapy in patients with vascular and post-traumatic cognitive impairment: some clinical observations].
    Olazarán-Rodríguez J; Cruz-Orduña I; Jiménez-Martín I
    Rev Neurol; 2004 May 16-31; 38(10):938-43. PubMed ID: 15175977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression.
    Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N
    Psychogeriatrics; 2016 Jan; 16(1):54-61. PubMed ID: 25919986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil treatment of topiramate-related cognitive dysfunction.
    Wheeler SD
    Headache; 2006 Feb; 46(2):332-5. PubMed ID: 16492246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of donepezil for cognitive rehabilitation after traumatic brain injury: a systematic review.
    Ballesteros J; Güemes I; Ibarra N; Quemada JI
    J Head Trauma Rehabil; 2008; 23(3):171-80. PubMed ID: 18520431
    [No Abstract]   [Full Text] [Related]  

  • 17. Mild cognitive impairment--no benefit from vitamin E, little from donepezil.
    Blacker D
    N Engl J Med; 2005 Jun; 352(23):2439-41. PubMed ID: 15829528
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression.
    McDermott CL; Gray SL
    Ann Pharmacother; 2012 Apr; 46(4):599-605. PubMed ID: 22414791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating cognitive deficits in multiple sclerosis: are we there yet?
    Doraiswamy PM; Rao SM
    Neurology; 2004 Nov; 63(9):1552-3. PubMed ID: 15534232
    [No Abstract]   [Full Text] [Related]  

  • 20. Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial.
    Marder K
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):390-1. PubMed ID: 12169217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.